1. Introduction {#sec1}
===============

Sponges, a group of sedentary organisms, cannot move and escape from predators. Most sponges are filter feeders pumping water to its body to obtain foods and oxygen and to expel wastes and may be threatened by microorganisms during filtering seawater rich in bacteria and fungi \[[@B1], [@B2]\]. In order to defend themselves against predators, pathogens and competitors, sponges may have developed to produce or accumulate secondary metabolites during their long evolution, such as feeding deterrent, antimicrobial, antifungal, and antifouling molecules. Interestingly, some of the compounds have also shown remarkable potency as drug candidates against various human diseases as discussed elsewhere \[[@B3]--[@B9]\].

In 1984, Schmitz and coworkers isolated tedanolide from the Caribbean marine sponge *Tedania ignis* \[[@B10]\]. Tedanolide is a unique 18-membered macrolide where lactonization occurs at a primary hydroxyl group instead of a common secondary one, and this class of macrolide has been reported to exhibit strong cytotoxicity at pico to nanomolar range \[[@B10], [@B11]\]. The unique structure in combination with promising biological activity leads tedanolide as an intriguing target for formal and total syntheses \[[@B12]--[@B14]\]. More recently, Meragelman and coworkers reported a macrolide named candidaspongiolide (**1**) related to tedanolide with modification at C-11 to C-15 from the marine sponge *Candidaspongia* sp. Candidaspongiolide exhibited potent cytotoxicity in NCI 60 cells panel with GI~50~ of 14 ng/mL \[[@B15]\], protein synthesis inhibition, and apoptosis induction \[[@B16]\].

In our continuing search for potential drug leads from Indonesian marine invertebrates \[[@B17], [@B18]\], we obtained a sponge whose extract showed cytotoxicity at 0.1 *μ*g/mL against NBT-T2 cells in a screening process. Purification of the extract provided candidaspongiolide (**1**) along with two new analogs **2**and **3**, which are the subject of this paper.

2. Materials and Methods {#sec2}
========================

2.1. Chemicals and Equipments {#sec2.1}
-----------------------------

Methanol (MeOH) used for extraction was of technical grade. Reagent grade solvents were used for isolating compounds **1**--**3**. Merck Si-60 (70--230 mesh) was used for silica gel column chromatography, while Merck Si-60 F~254~ for analytical TLC. HPLC was performed either on a Waters 510 pump with a Waters 486 UV detector and a Shodex RI-101 or on a Hitachi L-6000 pump with a Hitachi L-4000 UV detector and a Shodex RI-101 using a Mightysil Si-60 (10 × 250 mm) column. Optical rotations were measured on a Jasco P-1010 polarimeter using a cell with 3.5 mm aperture. IR spectra were recorded on a Jasco FT/IR-6100 instrument, whereas HRESIMS was measured on a Jeol JMS-T100LP spectrometer using reserpine or sodium trifluoroacetate as an internal standard. Most of ^1^H and ^13^C NMR spectra were measured in CDCl~3,~ while those of compound **3** were measured in CD~3~OD with TMS as an internal standard on a Jeol A500 and/or a Bruker AVANCE III-500 in CDCl~3~. The ^1^H and ^13^C chemical shifts were given in ppm, while coupling constants were in Hz.

2.2. Sponge {#sec2.2}
-----------

Specimens of the sponge tagged K09-02 was collected by hand using SCUBA at 15--25 m depth at Kupang, West Timor, East Nusa Tenggara, Indonesia on August 2009. By comparing underwater images of our specimen with that of the specimen of NCI group \[[@B15]\], it is likely to be the same sponge. The specimen was kept frozen until extraction. The sponge K09-02 may be an endemic species to this region. The colonies are grey in color and stand.

2.3. Extraction and Isolation {#sec2.3}
-----------------------------

After cutting into small pieces, the sponge (653 g, wet) was soaked in MeOH for 24 h for three times. Then, the solution was concentrated under vacuum to obtain a crude extract. The methanolic extract (17.0 g) was triturated with ethyl acetate (EtOAc) to provide a lipophilic fraction (2.7 g), which killed NBT-T2 cells at 0.1 *μ*g/mL. This fraction was subjected to a silica gel column eluting with stepwise gradient solvents (hexane : EtOAc = 2 : 1, 1 : 1, 1 : 2, 0 : 1, EtOAc : MeOH = 10 : 1) to afford ten fractions. Fraction 5 (126.0 mg) was purified by repetitive Si-60 HPLC using hexane-EtOAc mixtures to provide candidaspongiolide **1** (15.4 mg). Fraction 6 (70.8 mg) was also purified by Si-60 HPLC using a solvent system hexane : EtOAc = 2 : 1 to afford compound **2**(9.8 mg). Fraction 9 (107.1 mg) was also subjected to repetitive Si-60 HPLC using hexane : EtOAc = 1 : 6, EtOAc : CH~2~Cl~2~ : MeOH = 20 : 20 : 1, and EtOAc : CH~2~Cl~2~ : MeOH = 10 : 20 : 1 as solvent systems sequentially, to give compound **3**(21.8 mg). Isolation of these compounds was guided by cytotoxicity testing and NMR spectra.

2.4. Compound **1** {#sec2.4}
-------------------

Colorless glass, \[*α*\]~D~ ^25^ +69 (*c* 0.55, MeOH). IR *ν* ~max⁡~ (neat) 3419, 2925, 2854, 1742, 1715, 1456, 1372, 1234, 1086 cm^−1^. ^1^H and ^13^C NMR; see Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}. HR-ESIMS \[M+Na\]^+^   *m*/*z* 945.55514, 959.57079, 973.58884 (calcd for C~50~H~82~NaO~15~ ^+^ 945.55459 (Δ +0.58 ppm), C~51~H~84~NaO~15~ ^+^ 959.57024 (+0.57 ppm), and C~52~H~86~NaO~15~ ^+^ 973.58589 (+3.0 ppm)).

2.5. Compound **2** {#sec2.5}
-------------------

Colorless glass, \[*α*\]~D~ ^25^ +72 (*c* 0.75, MeOH). IR *ν* ~max⁡~ (neat) 3421, 2925, 2854, 1748, 1715, 1456 cm^−1^. ^1^H and ^13^C NMR; see Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}. HR-ESIMS \[M+Na\]^+^   *m*/*z* 903.54964, 917.56023, 931.57576, 945.60036 and 959.61056 (calcd for C~48~H~80~NaO~14~ ^+^ 903.54403 (Δ +6.2 ppm), C~49~H~82~NaO~14~ ^+^ 917.55968 (+0.60 ppm), C~50~H~84~NaO~14~ ^+^ 931.57533 (+0.46 ppm), C~51~H~86~NaO~14~ ^+^ 945.59098 (+9.9 ppm), and C~52~H~88~NaO~14~ ^+^ 959.60663 (+4.1 ppm)).

2.6. Compound **3** {#sec2.6}
-------------------

Yellow glass, \[*α*\]~D~ ^25^ +97 (*c* 0.35, MeOH). IR *ν* ~max⁡~ (neat) 3418, 2925, 2854, 1715, 1457, 1373, 1244, 1084, 995 cm^−1^. ^1^H and ^13^C NMR; see Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}. HR-ESIMS \[M+Na\]^+^   *m*/*z* 665.31522 (calcd for C~32~H~50~NaO~13~ ^+^ 665.31436 (+1.3 ppm)).

2.7. Acetylation {#sec2.7}
----------------

Compound **1** (0.2 mg) was dissolved in pyridine (50 *μ*L) and acetic anhydride (50 *μ*L). The mixture was stirred for three days under a nitrogen atmosphere at room temperature. After removal of excess reagents with nitrogen flow and vacuum, the reaction product **4** was checked with ^1^H NMR and ESIMS. Compound **2** was similarly treated to give **4**.

2.8. Compound **4**   from   **1** {#sec2.8}
----------------------------------

^1^H NMR: *δ* 5.65 dd (*J* = 2.7, 9.5 Hz), 5.52 m, 5.51 d (*J* = 10.1 Hz), 5.36 m, 5.34 dd (*J* = 2.2, 9.1 Hz), 5.28 dt (*J* = 2.3, 10.5 Hz), 5.07 d (*J* = 11.0 Hz), 4.79 d (*J* = 6.6 Hz), 4.54 dd (*J* = 2.0, 11.3 Hz), 4.25 dd (*J* = 2.3, 8.1 Hz), 4.13 dd (*J* = 6.3, 11.5 Hz), 3.43 s (3H), 3.34 dq (*J* = 10.0, 6.7 Hz), 3.29 dq (*J* = 10.5, 7.0 Hz), 3.01 dd (*J* = 9.2, 18.4 Hz), 2.88 d (*J* = 9.3 Hz), 2.60 dd (*J* = 2.6, 18.4 Hz), 2.35--2.4 m, 2.32 dd (*J* = 1.9, 9.3 Hz), 2.21 s (3H), 2.10 s (3H), 2.09 s (3H), 2.02 s (3H), 1.69 d (*J* = 1.1 Hz, 3H), 1.66 dd (*J* = 1.7, 6.8 Hz, 3H), 1.44 d (*J* = 7.1 Hz, 3H), 1.37 s (3H), 1.17 d (*J* = 7.1 Hz, 3H), 1.08 d (*J* = 6.6 Hz, 3H), 0.90 t (*J* = 6.1 Hz, 3H). HR-ESIMS *m*/*z* 1072.60225, 1086.60997, 1099.62465 (calcd for ^12^C~55~ ^13^CH~88~NaO~18~ ^+^ 1072.59019 (+11.24 ppm), ^12^C~56~ ^13^CH~90~NaO~18~ ^+^ 1086.60584 (+3.8 ppm), and C~58~H~92~NaO~18~ ^+^ 1099.61814 (+5.9 ppm)).

2.9. Compound **4** from **2** {#sec2.9}
------------------------------

^1^H NMR: *δ* 5.65 dd (*J* = 2.6, 9.8 Hz), 5.52 m, 5.51 d (*J* = 10.2 Hz), 5.37 m, 5.34 dd (*J* = 1.7, 9.1 Hz), 5.28 dt (*J* = 1.7, 10.5 Hz), 5.07 d (*J* = 10.9 Hz), 4.78 d (*J* = 6.3 Hz), 4.54 dd (*J* = 3.1, 11.7 Hz), 4.25 dd (*J* = 2.3, 8.1 Hz), 4.13 dd (*J* = 6.5, 11.3 Hz), 3.43 s (3H), 3.34 dq (*J* = 10.1, 5.7 Hz), 3.29 dq (*J* = 10.5, 7.2 Hz), 3.01 dd (*J* = 9.4, 18.6 Hz), 2.88 d (*J* = 9.2 Hz), 2.60 dd (*J* = 2.5, 18.6 Hz), 2.35--2.4 m, 2.32 (*J* = 1.9, 9.3 Hz), 2.22 s (3H), 2.10 s (3H), 2.09 s (3H), 2.02 s (3H), 1.70 d (*J* = 1.1 Hz, 3H), 1.62 dd (*J* = 1.7, 6.8 Hz, 3H), 1.44 d (*J* = 7.1 Hz, 3H), 1.37 s (3H), 1.17 d (*J* = 7.1 Hz, 3H), 1.08 d (*J* = 6.6 Hz, 3H), 0.90 t (*J* = 6.1 Hz, 3H). HR-ESIMS \[M+Na^+^\] *m*/*z* 1071.58258, 1085.60199, 1099.61165 (calcd for C~56~H~88~NaO~18~ ^+^ 1071.58629 (−4 ppm), C~57~H~90~NaO~18~ ^+^ 1085.60194 (−.5 ppm), and C~58~H~92~NaO~18~ ^+^ 1099.61759 (−5.9 ppm)).

2.10. Screening Process {#sec2.10}
-----------------------

NBT-T2 cells were purchased from Riken and used for cytotoxicity testing. NBT-T2 is a cell line derived from chemically induced rat bladder carcinoma cells \[[@B19]\]. The sponge extract was tested at 0.1, 1, and 10 *μ*g/mL in triplicate, while fractions were done at 0.01, 0.1, and 1 *μ*g/mL. The cells were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM) supplemented with Sigma antibiotic-antimycotic, Biowest fetal bovine serum, Gibco MEM nonessential amino acid in a Falcon 24-well plate or 48-well plate. After adding the extract or a fraction, cells were incubated for 24 h under 5% CO~2~ at 36°C \[[@B16]\]. Then, the cells were observed under a microscope to evaluate viability of cells whether the fractions were cytotoxic or not.

2.11. MTT Assay {#sec2.11}
---------------

Cultured cells were inoculated to a 96-well plate with approximate cell density of 1 × 10^4^ cells/mL in DMEM. After 24 h incubation, a series of DMSO solution of compounds **1**--**3** were applied to each well and the final concentrations were adjusted as 0, 1, 12.5, 25, 37.5, 50, 62.5, to 75 ng/mL. Cells were incubated for another 24 h, and the media were replaced with 20 *μ*L of 5 g/mL MTT solution in PBS and incubated for 3.5 h. After removal of PBS solution, an amount of 150 *μ*L of DMSO was added to each well and the cells were reincubated for 15 min prior to measurement with a Tecan microplate reader at 590 nm with reference filter at 620 nm \[[@B20], [@B21]\].

3. Results and Discussion {#sec3}
=========================

As an EtOAc soluble portion of a methanolic extract of the sponge K09-02 showed potent cytotoxicity against cultured NBT-T2 cells, the portion was separated repetitively on a silica gel column followed by Si-60 HPLC affording three compounds **1**, **2**, and **3**as shown in [Figure 1](#fig1){ref-type="fig"}.

By inspecting ^1^H and ^13^C NMR spectra of compound **1** together with database search (Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}, Figures  S1 and  S2 (Supplementary Materials available online at doi:10.5402/2011/852619)), we could readily identify that it is a member of candidaspongiolide, a series of 18-membered cytotoxic macrolide retaining one of fatty acid moieties from C~14~ to C~18~ at C-28 \[[@B15]\]. HR-ESIMS of our material exhibited molecular-related ions at*m*/*z* 945.55514, 959.57079, 973.58884 \[M+Na\]^+^ indicating that compound **1** is candidaspongiolide esterified with the homologs of three saturated fatty acids (palmitic, margaric, and stearic acids).

Compound **2** was obtained as a colorless glass with \[*α*\]~D~ ^25^ +72. After elucidation of its ^1^H and ^13^C NMR spectra, compound **2** was found to be an analog of **1**. However, the ^13^C NMR spectrum showed two carbonyl carbons at *δ* ~C~ 171.3 q (C-1) and 173.1 (C-35) instead of three in **1** ([Table 1](#tab1){ref-type="table"}, Figure  S3). As the signals for an acetoxy group (*δ* ~H~ 2.04 s, *δ* ~C~ 21.5 q) in **1** are missing in **2**, it was suggested that **2** is a deacetyl derivative of **1**. The lack of the acetyl group is in a good agreement with ^1^H NMR spectrum and COSY analysis showing that H-7 proton signal (*δ* ~H~ 4.12 d, *J*= 10.0 Hz) in **2** shifted to higher field than that (*δ* ~H~ 5.41 d, *J*= 10.7 Hz) in **1** ([Table 2](#tab2){ref-type="table"}). HR-ESIMS of **2** showed a series of sodiated ions \[M+Na\]^+^ at *m/z* 903.54964, 917.56023, 931.57576, 945.60036, and 959.61056 corresponding to the presence of C~16~ to C~20~ esters. For structural confirmation, compound **2** was acetylated to give tetraacetate **4**, which showed signals identical with **4** obtained from **1 (**Figure  S4). Compound **4** exhibited four acetyl signals at *δ* ~H~ 2.22 s, 2.10 s, 2.09 s, and 2.02 s and molecular-related ions corresponding to macrolide esters with C~16~ to C~18~ fatty acids.

Compound **3**was isolated as a yellowish glass with \[*α*\]~D~ ^25^ +97. Its molecular formula was established as C~32~H~50~O~13~ by observing a molecular-related ion at *m/z* 665.31522 \[M+Na\]^+^ in HR-ESIMS. ^1^H and ^13^C NMR spectra (Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}, Figures  S5 and  S6) revealed that compound **3** has a similar macrolide structure to that of compound **1** except for the lack of a fatty acid ester moiety and an acetate found in **1**. Higher field chemical shifts observed for H-7 (*δ* ~H~ 4.03) and H-28 (*δ* ~H~ 3.75) indicated that **3** is devoid of acyl groups. Close similarity of ^1^H and ^13^C NMR data of **3** to **1** ([Table 2](#tab2){ref-type="table"}) indicated that the macrolide core structure of compound**3**is identical to compound **1**.

All of natural compounds **1**--**3** exhibited potent cytotoxicity, IC~50~ 37, 4.7, and 19 ng/mL, against NBT-T2 cells. The result is not in good agreement with those reported by Meragelman and coworkers, that is, candidaspongiolide (**1**) showed stronger growth inhibition (GI~50~14 ng/mL) than the core compound (42 ng/mL) \[[@B15]\]. Additionally Paul et al. paperd the importance of a linear carbon chain on the cytotoxicity in the case of amphidinol \[[@B22]\]. The difference may be explained either by the number of cell lines or by different sensitivity of NBT-T2 cells.

The authors appreciate Professor Rob van Soest, University of Amsterdam, for showing a sponge image and suggestions on the sponge identification and Mr. T. Iha for mass measurements. they thank PharmaMar S. A. for financial support.

![Structures of compounds (**1**)--(**4**).](PHARMACEUTICS2011-852619.001){#fig1}

###### 

^13^C NMR data for compounds **1**, **2**, and **3**.

  C no.   1^15,a^      1^a^         2^a^         3^b^
  ------- ------------ ------------ ------------ ------------
  1       171.3 qC     171.3 qC     171.3 qC     171.3 qC
  2       70.7 CH      70.8 CH      70.8 CH      72.9 CH
  3       83.4 CH      83.3 CH      83.1 CH      84.7 CH
  4       47.8 CH      47.7 CH      47.9 CH      49.5 CH
  5       214.6 qC     214.9 qC     216.2 qC     217.6 qC
  6       48.5 CH      48.3 CH      49.8 CH      51.1 CH
  7       80.1 CH      80.1 CH      79.2 CH      79.9 CH
  8       131.6 qC     132.0 qC     136.2 qC     139.0 qC
  9       132.0 CH     131.7 CH     129.4 CH     129.8 CH
  10      46.2 CH      46.1 CH      45.9 CH      46.5 CH
  11      211.5 qC     211.7 qC     211.9 qC     212.7 qC
  12      42.6 CH~2~   42.7 CH~2~   42.5 CH~2~   44.3 CH~2~
  13      68.9 CH      68.8 CH      69.0 CH      69.3 CH
  14      81.6 qC      81.6 qC      81.6 qC      85.0 qC
  15      210.8 qC     211.0 qC     211.2 qC     216.5 qC
  16      46.9 CH      47.0 CH      46.9 CH      46.4 CH
  17      77.8 CH      77.7 CH      77.7 CH      78.4 CH
  18      62.7 qC      62.7 qC      62.6 qC      63.9 qC
  19      67.1 CH      67.0 CH      67.0 CH      67.4CH
  20      31.1 CH      31.1 CH      30.9 CH      32.4 CH
  21      129.7 CH     129.4 CH     129.6 CH     131.6 CH
  22      125.5 CH     125.5 CH     125.4 CH     126.2 CH
  23      13.5 CH~3~   13.4 CH~3~   13.3 CH~3~   13.3 CH~3~
  24      14.6 CH~3~   14.5 CH~3~   14.4 CH~3~   15.3 CH~3~
  25      14.7 CH~3~   14.5 CH~3~   15.0 CH~3~   15.6 CH~3~
  26      10.8 CH~3~   10.7 CH~3~   10.2 CH~3~   10.5 CH~3~
  27      16.3 CH~3~   16.2 CH~3~   16.4 CH~3~   15.7 CH~3~
  28      63.5 CH~2~   63.5 CH~2~   63.5 CH~2~   65.7 CH~2~
  29      63.2 CH~2~   63.2 CH~2~   62.8 CH~2~   64.8 CH~2~
  30      11.1 CH~3~   11.0 CH~3~   10.9 CH~3~   11.5 CH~3~
  31      18.6 CH~3~   18.4 CH~3~   18.3 CH~3~   18.7 CH~3~
  32      60.3 CH~3~   60.3 CH~3~   60.3 CH~3~   60.3 CH~3~
  33      169.5 qC     169.9 qC     ---          ---
  34      21.6 CH~3~   21.5 CH~3~   ---          ---
  35      173.5 qC     173.7 qC     173.6 qC     ---
  36      34.2 CH~2~   34.1 CH~2~   34.0 CH~2~   ---
  37      29.0 CH~2~   29.0 CH~2~   29.1 CH~2~   ---

^a^Measured in CDCl~3~. ^b^Measured in CD~3~OD.

###### 

^1^H NMR data for compounds **1**, **2**, and **3** (*J* in Hz).

  C no.                  1^15,a^                1^a^                         2^a^                   3^b^
  ---------------------- ---------------------- ---------------------------- ---------------------- ----------------------------
  1                      ---                    ---                          ---                    ---
  2                      3.96 dd (1.0, 7.3)     3.96 dd (1.3, 7.5)           3.98 dd (1.3, 7.8)     3.76 d (2.2)
  3                      3.64 dd (1.3, 7.8)     3.67 dd (1.3, 8.0)           3.67 dd (1.3, 8.4)     3.81 dd (2.2, 9.8)
  4                      3.12 m                 3.13 dd (8.0, 7.1)           3.10 dq (8.4, 7.3)     3.16 dq (9.8, 7.1)
  5                      ---                    ---                          ---                    ---
  6                      3.18 dq (10.7, 7.3)    3.22 dq (10.7, 6.8)          3.04 dq (9.8, 6.8)     3.16 dq (10.0, 7.1)
  7                      5.39 d (10.7)          5.41 d (10.7)                4.12 d (10.0)          4.03 d (10.0)
  8                      ---                    ---                          ---                    ---
  9                      5.60 d (9.3)           5.62 d (9.6)                 5.48 d (10.5)          5.33 d (9.3)
  10                     3.38 dq (9.3, 6.8)     3.41 dq (9.6, 7.0)           3.49 dq (10.5, 7.1)    3.36 dq (9.3, 6.8)
  11                     ---                    ---                          ---                    ---
  12                     2.66 dd (9.8, 16.1)    2.69 dd (9.8, 16.1)          2.72 dd (9.8, 16.1)    2.75 dd (9.5, 17.6)
  2.49 dd (2.4, 16.1)    2.49 dd (2.5, 16.1)    2.51 dd (2.0, 16.1)          2.23 dd (2.0, 17.6)    
  13                     4.40 m                 4.42 m                       4.39 dt (2.0, 9.8)     4.44 dd (2.9, 9.5)
  14                     ---                    ---                          ---                    ---
  15                     ---                    ---                          ---                    ---
  16                     4.02 dt (3.9, 10.9)    4.03 ddd (3.9, 10.5, 11.5)   4.09 dt (3.9, 11.0)    4.08 ddd (3.9, 10.8, 11.4)
  17                     3.12 m                 3.13 m                       3.20 dd (11.0)         3.20 d (10.7)
  18                     ---                    ---                          ---                    ---
  19                     2.56 d (9.3)           2.59 d (9.3)                 2.58 d (9.8)           2.62 d (9.3)
  20                     2.44 m                 2.47 m                       2.47 m                 2.48 m
  21                     5.23 dt (1.5, 10.7)    5.25 ddd (0.7, 10.2, 10.9)   5.24 dt (1.5, 10.5)    5.31 m
  22                     5.48 dq (10.7, 6.8)    5.51 dq (10.9, 6.8)          5.49 dq (10.5, 6.8)    5.51 dq (10.7, 6.8)
  23                     1.59 dd (1.5, 6.8)     1.62 dd (1.2, 6.8)           1.62 dd (1.5, 6.8)     1.62 dd (1.7, 6.8)
  24                     1.18 d (6.8)           1.21 d (7.1)                 1.21 d (7.3)           1.23 d (7.1)
  25                     1.13 d (7.3)           1.16 d (6.8)                 1.28 d (6.8)           1.26 d (7.1)
  26                     1.54 brd (1.0)         1.59 d (0.8)                 1.63 s                 1.65 d (1.5)
  27                     1.07 d (6.8)           1.09 d (7.0)                 1.10 d (7.1)           1.03 d (6.8)
  28                     4.44 d (11.7)          4.46 d (11.5)                4.45 d (11.5)          3.75 d (10.5)
  4.19 d (11.7)          4.22 d (11.5)          4.21 d (11.5)                3.76 d (10.5)          
  29                     4.17 dd (3.7, 9.8)     4.20 dd (3.7, 10.2)          4.24 dd (3.0, 9.5)     4.35 dd (3.9, 10.5)
  4.10 dd (10.2, 10.9)   4.12 dd (10.2, 11.2)   4.08 m                       3.91 dd (10.5, 11.4)   
  30                     1.38 s                 1.42 s                       1.42 s                 1.35 s
  31                     1.11 d (6.4)           1.13 d (6.3)                 1.14 d (6.6)           1.11 d (6.6)
  32                     3.28 s                 3.31 s                       3.30 s                 3.39 s
  33                     ---                    ---                          ---                    ---
  34                     2.01 s                 2.04 s                       ---                    ---
  35                     ---                    ---                          ---                    ---
  36                     2.24 t (7.6)           2.27 t (7.6)                 2.27 t (11.8)          
  37                     1.53 brs               1.59 brs                     1.25 brs               
  OH-2                   2.85 d (7.3)           2.92 d (7.5)                 2.99 d (7.8)           2.92 d (7.5)
  OH-13                  ---                                                 4.71 s                 

^a^Measured in CDCl~3~. ^b^Measured in CD~3~OD.
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